Prostate brachytherapy: Why do we ignore the evidence?

Under‐utilisation of high‐dose‐rate brachytherapy boost in men with intermediate‐high risk prostate cancer treated with external beam radiotherapy

“…While there is requirement in US Accreditation Council of Graduate Medical Education (ACGME) Radiation Oncology Program that trainees should perform no fewer than five interstitial and 15 intra‐cavitary BT implants during their training, there is no stipulation on the minimum number of brachytherapy cases that have to be performed by trainees in the Australian and New Zealand radiation oncology training programme. Hence, there is reason to be concern that the continue decline in use of HDR‐BT may result in Australian and New Zealand radiation oncology trainees having a lack of exposure and training opportunity on HDR‐BT, which in the longer terms may translate into a shortfall of radiation oncologists proficient in HDR‐BT, and further under‐utilisation of HDR‐BT in the future …”